GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Institutional Ownership

Exact Therapeutics AS (OSL:EXTX) Institutional Ownership : 5.79% (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Exact Therapeutics AS's institutional ownership is 5.79%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Exact Therapeutics AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Exact Therapeutics AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Exact Therapeutics AS Institutional Ownership Historical Data

The historical data trend for Exact Therapeutics AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Institutional Ownership Chart

Exact Therapeutics AS Historical Data

The historical data trend for Exact Therapeutics AS can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 6.12 6.12 6.12 6.12 6.12 6.12 5.79 5.79 5.79 5.79

Exact Therapeutics AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Exact Therapeutics AS (OSL:EXTX) Business Description

Traded in Other Exchanges
N/A
Address
Ostre Aker vei 19, Oslo, NOR, 0581
Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines